Examining Exelixis Inc (EXEL)’s cash flow and debt position

In the latest session, Exelixis Inc (NASDAQ: EXEL) closed at $20.22 up 0.25% from its previous closing price of $20.17. In other words, the price has increased by $+0.05 from its previous closing price. On the day, 2423668 shares were traded. EXEL stock price reached its highest trading level at $20.42 during the session, while it also had its lowest trading level at $20.10.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.


For a deeper understanding of Exelixis Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.93. For the most recent quarter (mrq), Quick Ratio is recorded 3.30 and its Current Ratio is at 3.34. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 19, 2023, initiated with a Buy rating and assigned the stock a target price of $27.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 14 when Haley Patrick J. sold 50,000 shares for $23.35 per share. The transaction valued at 1,167,500 led to the insider holds 307,687 shares of the business.

Hessekiel Jeffrey sold 25,000 shares of EXEL for $575,250 on Dec 13. The EVP, General Counsel & Sec now owns 533,345 shares after completing the transaction at $23.01 per share. On Dec 12, another insider, Haley Patrick J., who serves as the EVP, Commercial of the company, sold 14,149 shares for $22.50 each. As a result, the insider received 318,352 and left with 307,687 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 6.13B and an Enterprise Value of 5.32B. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 31.24, and their Forward P/E ratio for the next fiscal year is 13.34. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.64. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.35 while its Price-to-Book (P/B) ratio in mrq is 2.70. Its current Enterprise Value per Revenue stands at 2.91 whereas that against EBITDA is 27.07.

Stock Price History:

Over the past 52 weeks, EXEL has reached a high of $24.34, while it has fallen to a 52-week low of $16.15. The 50-Day Moving Average of the stock is 22.53, while the 200-Day Moving Average is calculated to be 20.96.

Shares Statistics:

For the past three months, EXEL has traded an average of 1.12 shares per day and 2.05M over the past ten days. A total of 302.79M shares are outstanding, with a floating share count of 293.63M. Insiders hold about 3.15% of the company’s shares, while institutions hold 88.15% stake in the company. Shares short for EXEL as of Jan 31, 2024 were 7.31M with a Short Ratio of 3.51, compared to 8.11M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 2.41% and a Short% of Float of 2.77%.

Earnings Estimates

There are 12 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.23 for the current quarter, with a high estimate of $0.47 and a low estimate of $0.11, while EPS last year was $0.12. The consensus estimate for the next quarter is $0.31, with high estimates of $0.42 and low estimates of $0.19.

Analysts are recommending an EPS of between $1.36 and $0.82 for the fiscal current year, implying an average EPS of $1.19. EPS for the following year is $1.48, with 14 analysts recommending between $2.07 and $1.1.

Revenue Estimates

A total of 15 analysts believe the company’s revenue will be $448.64M this quarter.It ranges from a high estimate of $481M to a low estimate of $409.2M. As of the current estimate, Exelixis Inc’s year-ago sales were $408.79M, an estimated increase of 9.70% from the year-ago figure. For the next quarter, 15 analysts are estimating revenue of $472.23M, an increase of 0.50% less than the figure of $9.70% in the same quarter last year. There is a high estimate of $498.53M for the next quarter, whereas the lowest estimate is $449M.

A total of 21 analysts have provided revenue estimates for EXEL’s current fiscal year. The highest revenue estimate was $1.97B, while the lowest revenue estimate was $1.81B, resulting in an average revenue estimate of $1.9B. In the same quarter a year ago, actual revenue was $1.83B, up 3.90% from the average estimate. Based on 19 analysts’ estimates, the company’s revenue will be $2.09B in the next fiscal year. The high estimate is $2.41B and the low estimate is $1.91B. The average revenue growth estimate for next year is up 9.70% from the average revenue estimate for this year.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular